SCHEMBL17447178

SCHEMBL17447178

Cc1ccccc1-c1ccc(N(c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4ccc(-c5ccccc5)cc4)cc3)cc2)c2ccc3c(c2)C(C)(C)c2ccccc2-3)cc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 8/20 0.39
▸ MCL1 Q07820 1/20 0.33
▸ SLC6A9 P48067 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ GRIA1 P42261 1/20 0.31
▸ CACNG8 Q8WXS5 1/20 0.31
▸ MLNR O43193 1/20 0.30
▸ NR1I2 O75469 1/20 0.30
▸ CHRM2 P08172 1/20 0.30
▸ ADRB1 P08588 1/20 0.30
▸ HTR1A P08908 1/20 0.30
▸ ADRA2A P08913 1/20 0.30
▸ CHRM1 P11229 1/20 0.30
▸ DRD2 P14416 1/20 0.30
▸ ADRA2B P18089 1/20 0.30
▸ ADRA2C P18825 1/20 0.30
▸ CHRM3 P20309 1/20 0.30
▸ DRD1 P21728 1/20 0.30
▸ SLC6A2 P23975 1/20 0.30
▸ HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15384735 0.97 PDK2 (0.39) PDK2MCL1SLC6A9GRIA1CACNG8
SCHEMBL17447205 0.97 PDK2 (0.40) PDK2MCL1ESR2GRIA1CACNG8
SCHEMBL17808008 0.94 PDK2 (0.38) PDK2MCL1ESR2
SCHEMBL19531981 0.94 ESR2 (0.39) PDK2MCL1ESR2MLNRNR1I2
SCHEMBL15866067 0.93 PDK2 (0.39) PDK2ESR2MLNRNR1I2CHRM2
SCHEMBL15866065 0.93 PDK2 (0.39) PDK2ESR2MLNRNR1I2CHRM2
SCHEMBL15791645 0.93 PDK2 (0.36) PDK2MCL1SLC6A9S1PR1
SCHEMBL20726889 0.93 PDK2 (0.37) PDK2MCL1SLC6A9NPC1RAB9A
SCHEMBL12758709 0.92 PDK2 (0.38) PDK2ESR2MLNRNR1I2CHRM2
SCHEMBL15576857 0.92 PDK2 (0.38) PDK2ESR2MLNRNR1I2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160020403-A1 ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE IDEMITSU KOSAN CO., LTD. (JP) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160020403-A1 ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE SLC18A1, SLC18A2, AOC2 PDK2 833/4885MCL1 4180/4885SLC6A9 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback